Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01882725 · ClinicalTrials.gov registry record · NA
Study of Low Level Laser Light Therapy to Improve Blood Circulation in People With Chronic Heel Pain
A NA study, sponsored by Erchonia Corporation.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT01882725: Completed NA study, sponsored by Erchonia Corporation.
NCT01882725 is a NA study that has completed, run by Erchonia Corporation. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01882725, a NA study, has completed, sponsored by Erchonia Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether low level laser light therapy is effective in increasing local blood circulation in people with chronic heel pain arising from plantar fasciitis.
Primary Outcome
Skin Perfusion Pressure (SPP) measured peripheral microcirculation or skin perfusion using a laser Doppler sensor and a pressure cuff to evaluate reactive hyperemia, the transient increase in blood flow that occurs following a brief period of ischemia. The SPP value was measured in mmHg. The per cent (%) change in mean Skin Perfusion Pressure (SPP) in mmHg was calculated as the % change in measurements from before the first procedure administration with the Erchonia® HPS Laser to after the sixt
Interventions
- DEVICE Erchonia HP Scanner (HPS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2013-06 |
| Est. Completion | 2013-09 |
| Phase | NA |
What the finished NCT01882725 record still lists
NCT01882725 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Erchonia HP Scanner (HPS) is the first listed.
NCT01882725 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01882725 about?
NCT01882725 is a clinical study titled "Study of Low Level Laser Light Therapy to Improve Blood Circulation in People With Chronic Heel Pain". The purpose of this study is to determine whether low level laser light therapy is effective in increasing local blood circulation in people with chronic heel pain arising from plantar fasciitis.
What is the current status of trial NCT01882725?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2013-06. Estimated completion is 2013-09.
What interventions are being tested in trial NCT01882725?
The interventions under investigation include: Erchonia HP Scanner (HPS) (DEVICE).
Who is sponsoring clinical trial NCT01882725?
This trial is sponsored by Erchonia Corporation, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01882725's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia